Join The Waitlist

A Regulation A+ offering is an SEC-qualified investment offering that allows companies like SpotitEarly to raise capital from both accredited and non-accredited investors. It is sometimes referred to as a “mini-IPO” because companies are required to provide public disclosures and audited financial statements, while making the investment available to a broad public audience. Regulation A+ also provides a framework that enables companies to raise meaningful amounts of capital to support growth and development.

Since inception, SpotitEarly has raised over $20 million from venture capital firms, high net worth investors, and innovation grants, and has reached meaningful development milestones in its at home, breath based early cancer detection test for multiple cancer types. Through the Regulation A+ offering, individual investors in the U.S. and internationally are able to participate at a time when the company is still regarded as being in its early stages, with an accessible minimum investment and SEC oversight. This offering is intended to support the Company’s efforts to advance the commercialization of its test and expand its presence in the U.S. market. It also enables individuals who believe in the mission and long term vision of expanding early cancer detection, by combining biological insight with advanced technology, to take part in the Company’s continued development. Institutional and accredited investors may continue to invest through the Company’s separate private offering conducted under Regulation D.

Anyone 18 or older can invest, accredited and non-accredited investors. U.S. residents may invest directly, and international investors may participate depending on their country’s laws.

The minimum investment for this Reg A+ offering is $1,000, enabling broader participation while supporting our mission of transforming early cancer detection.

Yes. The maximum amount for a single investment in the Regulation A+ offering is $249,999. Investors interested in making larger investments, ranging from $250,000 up to $20 million, may be eligible for volume-based pricing adjustments of up to 35%, subject to eligibility. Eligible investors may select the “Institutional” option in the investment selection widget or contact the Company directly at invest@spotitearly.com for additional information.

Investments are made online. You will select your investment amount, complete a short form, and then be directed to the secure online portal of Manhattan Street Capital, the Company’s regulated and secured funding partner, to complete your investment and submit payment via ACH, credit card, check, or wire transfer.

Both SpotitEarly and Manhattan Street Capital, the Company’s regulated funding partner, use secure, encrypted systems and third-party compliance providers to protect investor information and process investments in accordance with applicable regulatory standards.

Investors receive shares of SpotitEarly Inc, just like traditional early-stage startup equity. Details about share type, price per share, investor rights, and offering terms are provided in our SEC-qualified Offering Circular.

Proceeds will support clinical studies, U.S. commercialization targeted for 2027 and operational expansion, continued development of our AI scent-detection platform and laboratory infrastructure.

Shares purchased in a Reg A+ offering are not listed on a public exchange and currently have no secondary market. Liquidity may only occur if the company is acquired by a public company, listed on a major exchange like the NASDAQ or NYSE, or establishes an approved secondary market in the future.

Our SEC-qualified Offering Circular, including all terms and risk disclosures, is available on our investment page and on the SEC’s website. We strongly recommend that all potential investors read it before investing. **link to the Offering Circular***

You will receive a confirmation email, an account at our SEC approved Transfer Agent to access your shares online, updates on the status of your investment, and periodic company updates as part of our investor communications program.

Yes. Reg A+ offerings have a specific fundraising window. Details and updates will be listed directly on the investment page. Investments are accepted on a first-come, first-served basis until the maximum amount is reached or the company ends the offering.

SpotitEarly pairs highly trained detection dogs with proprietary AI analysis to identify early cancer odor signatures in breath. Our technology aims to make early detection accurate, accessible, non-invasive, and available from home.

Yes. Investors will receive periodic updates, including clinical milestones, operational progress, and major company announcements. Reg A+ requires certain ongoing disclosures to investors, which include annual Audited financial statements and six month management financial statements.

No. While Reg A+ allows public participation, this is not a donation or rewards-based crowdfunding campaign. Investors are purchasing equity in SpotitEarly and are subject to the same risks and potential rewards as traditional early-stage investors.

Yes. Non-accredited investors may invest up to 10% of the greater of their annual income or net worth, as defined by SEC rules. Accredited investors are not subject to this limitation.

Your investment will be considered pending until funds have cleared and the Company has formally accepted the investment and issued your shares. Once accepted, shares will be issued electronically and reflected in your investor account with the Company’s SEC-approved transfer agent. This process may take up to 21 days, though it is often completed sooner.

Yes. SpotitEarly reserves the right to reject or cancel any investment for compliance, regulatory, or operational reasons, even after funds have been submitted.

SpotitEarly does not charge investors a fee to invest directly. However, payment processors or financial institutions may charge transaction or wire fees.